M. Panisset

发表

Translated mutation in the Nurr1 gene as a cause for Parkinson's disease

L. Racacho, D. Bulman, D. Grimes, 2006, Movement disorders : official journal of the Movement Disorder Society.

Exome sequencing identifies FUS mutations as a cause of essential tremor.

G. Rouleau, J. Rivière, M. Panisset, 2012, American journal of human genetics.

The detection of tremor during slow alternating movements performed by patients with early Parkinson’s disease

A. Sadikot, C. Duval, M. Panisset, 2004, Experimental Brain Research.

Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada

N. Jodoin, A. Fasano, C. Honey, 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia

J. Carrier, J. Montplaisir, M. Bédard, 2004, Neurology.

REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease

Jean-François Gagnon, Véronique Latreille, Michel Panisset, 2017, Sleep.

Sleep spindles in Parkinson's disease may predict the development of dementia

Jean-François Gagnon, Julie Carrier, Véronique Latreille, 2015, Neurobiology of Aging.

Subcortical aphasia. Commentaries. Reply

Steven L. Small, Claus-W. Wallesch, Stefano F. Cappa, 1997 .

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

John Seibyl, Mark Stacy, Stanley Fahn, 2004, Archives of neurology.

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

John Seibyl, Anthony E. Lang, Stanley Fahn, 2000, JAMA.

Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease

M. Panisset, F. Beaudry, Stephen Nuara, 2021, Neuropharmacology.

Neural substrates of cognitive skill learning in Parkinson’s disease

A. Dagher, J. Doyon, M. Panisset, 2008, Brain and Cognition.

Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years.

M. Panisset, M. Bouchard, D. Mergler, 2007, American journal of industrial medicine.

Development and evaluation of a dyadic intervention for elderly couples living with moderate-stage Parkinson disease.

N. Jodoin, F. Ducharme, M. Panisset, 2015, Applied nursing research : ANR.

Visuo‐spatial dysgnosia and Balint's syndrome as major symptoms of probable Alzheimer's disease

M. Panisset, P. Davous, F. Boiler, 1996 .

Brain atrophy in Parkinson's disease with polysomnography-confirmed REM sleep behavior disorder.

O. Monchi, J. Carrier, R. Postuma, 2019, Sleep.

Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.

A. Ptito, A. Dagher, A. Sadikot, 2008, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository

A. Desautels, O. Monchi, A. Dagher, 2019, Journal of Parkinson's disease.

Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson’s Disease

E. Irving, R. Postuma, M. Panisset, 2017, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

LINGO1 Variants in the French-Canadian Population

G. Rouleau, J. Rivière, M. Panisset, 2011, PloS one.

Treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial with a neurotrophic agent

M. Panisset, S. Gauthier, M. Windisch, 2000, Neurobiology of Aging.

54-1 Advances in the diagnosis of Alzheimer's disease

J. Poirier, M. Panisset, S. Gauthier, 1997, Biological Psychiatry.

Language impairment and rate of cognitive decline in Alzheimer's disease.

F. Boller, M. Panisset, J. Michot, 1994, Dementia.

Neurofilament M gene in a French-Canadian Population with Parkinson’s Disease

D. Bulman, D. Grimes, F. Han, 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease.

J. Montplaisir, M. Panisset, J. Gagnon, 2006, Sleep.

LRRK2 Screening in a Canadian Parkinson's Disease Cohort

L. Racacho, D. Bulman, D. Grimes, 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Current diagnostic methods and outcome variables for clinical investigation of Alzheimer's disease.

S. Gauthier, M. Panisset, 1998, Journal of neural transmission. Supplementum.

Multiple cranial neuropathy as a feature of internal carotid artery dissection.

M. Panisset, B. Eidelman, 1990, Stroke.

Preliminary evidence of neurotoxicity associated with eating fish from the Upper St. Lawrence River Lakes.

F. Larribe, M. Panisset, D. Mergler, 1998, Neurotoxicology.

Commentary on “Subcortical Aphasia” by Stephen E. Nadeau and Bruce Crosson

M. Panisset, M. Simard, 1997, Brain and Language.

Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease

R. Postuma, J. Montplaisir, M. Panisset, 2009, Annals of neurology.

Manganese cumulative exposure and symptoms: a follow-up study of alloy workers.

M. Panisset, M. Bouchard, D. Mergler, 2008, Neurotoxicology.

Behavioural Correlates of Cognitive Skill Learning in Parkinson’s Disease

A. Dagher, J. Doyon, M. Panisset, 2008 .

Salivary production in Parkinson's disease

M. Panisset, M. Wiseman, Melisa Proulx, 2005, Movement disorders : official journal of the Movement Disorder Society.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Stephanie D. Wilson, S. Ellias, J. Nutt, 2014, JAMA neurology.

The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study

R. Doody, C. Clark, A. Heyman, 1997, Neurology.

Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis

M. Panisset, D. Nguyen, C. Odier, 2010, Journal of Neurology.

Eligibility Criteria for Deep Brain Stimulation in Parkinson’s Disease, Tremor, and Dystonia

A. Fasano, C. Honey, S. Fox, 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Severe impairment battery. A neuropsychological test for severely demented patients.

F. Boller, J. Saxton, M. Panisset, 1994, Archives of neurology.

Absence of Mutation Enrichment for Genes Phylogenetically Conserved in the Olivocerebellar Motor Circuitry in a Cohort of Canadian Essential Tremor Cases

A. Rajput, G. Rouleau, M. Panisset, 2018, Molecular Neurobiology.

Teneurin transmembrane protein 4 is not a cause for essential tremor in a Canadian population

A. Rajput, G. Rouleau, M. Panisset, 2017, Movement disorders : official journal of the Movement Disorder Society.

Genome-wide association study in essential tremor identifies three new loci

Dietrich Haubenberger, Mark Hallett, Günther Deuschl, 2016, Brain : a journal of neurology.

Enteral Feeding Using Levodopa‐Carbidopa Intestinal Gel Percutaneous Endoscopic Gastrostomy Tube

N. Jodoin, M. Panisset, S. Chouinard, 2017, Movement disorders clinical practice.

The token test: Validity and diagnostic power in Alzheimer's disease

James T. Becker, Michel Panisset, J. Becker, 1989 .

Characteristics of the memory loss of a patient with Wernicke-Korsakoff's syndrome without alcoholism

J. Becker, J. Furman, M. Panisset, 1990, Neuropsychologia.

Alzheimer's disease: current knowledge, management and research.

S. Gauthier, J. Poirier, M. Panisset, 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Apolipoprotein E: A Novel Therapeutic Target for the Treatment of Alzheimer’s Disease

J. Poirier, M. Panisset, 2002 .

Executive functions in frontotemporal dementia and Lewy body dementia.

Sylvie Belleville, Bernadette Ska, Howard Chertkow, 2009, Neuropsychology.

Physical activity in advanced Parkinson's disease: impact of subthalamic deep brain stimulation.

A. Sadikot, N. Jodoin, J. Daneault, 2015, Journal of Parkinson's disease.

Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease

R. Barker, F. Cicchetti, S. Mason, 2019, Neurobiology of Disease.

Trial designs and outcome variables in anti-dementia drug testing

M. Panisset, S. Gauthier, 1994 .

Manganese Neurotoxicity: Behavioral, Pathological, and Biochemical Effects Following Various Routes of Exposure

M. Panisset, L. Normandin, J. Zayed, 2002, Reviews on environmental health.

Impact of standard of care for psychosis in Parkinson disease

A. Lang, O. Suchowersky, M. Panisset, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Medical Management of Parkinson’s Disease after Initiation of Deep Brain Stimulation

A. Fasano, C. Honey, M. Jog, 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

A. Sadikot, Benoit Carignan, J. Daneault, 2013, BMC Medicine.

Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset.

M. Panisset, F. Beaudry, Stephen Nuara, 2020, European journal of pharmacology.

STUDIES ON MYCOBACTERIA: I. CYTOCHEMICAL STUDY AND CHEMICAL ANALYSIS OF THE LIPIDS OF MYCOBACTERIUM MARIANUM

M. Panisset, V. Portelance, Soeur Marie Suzanne, 1956 .

REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia

J. Doyon, R. Postuma, J. Montplaisir, 2007, Neurology.

Observational Study of the Relation between Parkinson's Disease and Sleep Apnea.

C. Wolfson, R. Postuma, M. Panisset, 2015, Journal of Parkinson's disease.

Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.

Jean-François Gagnon, Julie Carrier, Véronique Latreille, 2016, Brain : a journal of neurology.

Prevalence of Convergence Insufficiency in Parkinson's Disease

E. Irving, R. Postuma, M. Panisset, 2017, Movement disorders clinical practice.

Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study

R. Postuma, J. Montplaisir, M. Panisset, 2012, Movement disorders : official journal of the Movement Disorder Society.

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

C. Christine, D. Rottenberg, K. Black, 2012, Neurology.

Neuropsychiatric correlates of cerebral white-matter radiolucencies in probable Alzheimer's disease.

J. Becker, C. Reynolds, O. Lopez, 1992, Archives of neurology.

Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent

S. Gauthier, M. Panisset, A. T. N. Group, 2002, Journal of Neural Transmission.

Subthalamic stimulation improves motor function but not home and neighborhood mobility

A. Sadikot, N. Jodoin, J. Daneault, 2014, Movement disorders : official journal of the Movement Disorder Society.

The error negativity in nonmedicated and medicated patients with Parkinson’s disease

S. Segalowitz, J. Dywan, B. Stemmer, 2007, Clinical Neurophysiology.

Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant.

M. Panisset, M. Bouchard, D. Mergler, 2007, Neurotoxicology.

Is there seasonal variation in risk of Parkinson's disease?

A. Lang, C. Wolfson, R. Postuma, 2007, Movement disorders : official journal of the Movement Disorder Society.

REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease

J. Carrier, J. Montplaisir, M. Bédard, 2002, Neurology.

Freezing of gait in Parkinson's disease.

Michel Panisset, M. Panisset, 2004, Neurologic clinics.

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.

Bruce H. Morimoto, J. Jankovic, C. Jack, 2019, Parkinsonism & related disorders.

Sleep and quantitative EEG in patients with progressive supranuclear palsy

S. Gauthier, J. Montplaisir, M. Bédard, 1997, Neurology.

Clinical trials in cognitive impairment in the elderly

F. Boller, M. Panisset, F. Forette, 1992, Aging.

Deep Brain Stimulation Target Selection for Parkinson’s Disease

Suneil K. Kalia, A. Fasano, C. Honey, 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Manganese neurotoxicity, a continuum of dysfunction: results from a community based study.

A Beuter, D Mergler, R Edwards, 1999, Neurotoxicology.

The relationship between physiological tremor and the performance of rapid alternating movements in healthy elderly subjects

A. Sadikot, C. Duval, M. Panisset, 2001, Experimental Brain Research.

The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson’s disease

Abbas F. Sadikot, Christian Duval, Antonio P. Strafella, 2006, Experimental Brain Research.

Evidence that ventrolateral thalamotomy may eliminate the supraspinal component of both pathological and physiological tremors

Gilles Bertrand, Abbas F. Sadikot, Christian Duval, 2000, Experimental Brain Research.

Glucocerebrosidase Mutations in a French-Canadian Parkinson's Disease Cohort

N. Jodoin, G. Rouleau, J. Rivière, 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Bradykinesia in patients with essential tremor

A. Sadikot, C. Duval, M. Panisset, 2006, Brain Research.

The effect of Trager therapy on the level of evoked stretch responses in patients with Parkinson's disease and rigidity.

J. Boucher, A. Leroux, C. Duval, 2002, Journal of manipulative and physiological therapeutics.

Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.

William W. McDonald, C. Christine, D. Rottenberg, 2014, Parkinsonism & related disorders.

Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

R. Hauser, G. Abbruzzese, M. Panisset, 2009, Movement disorders : official journal of the Movement Disorder Society.

Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series

M. Panisset, P. Huot, L. Sid-Otmane, 2020, Clinical neuropharmacology.

Detecting the Cognitive Prodrome of Dementia in Parkinson's Disease.

R. Postuma, J. Montplaisir, M. Panisset, 2020, Journal of Parkinson's disease.

Open-Label Study of Sleep Disturbances in Patients with Parkinson’s Disease Treated with Rasagiline

M. Panisset, S. Chouinard, J. Stril, 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Predictors of dementia in Parkinson disease

R. Postuma, J. Montplaisir, M. Panisset, 2014, Neurology.

Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)

M. Panisset, Jack J. Chen, J. Conner, 2014, Pharmacotherapy.

A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists

Niem Tu Huynh, M. Panisset, P. Huot, 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients

J. Growdon, J. Friedman, M. Mcdermott, 1998, Neurology.

Increased Prevalence of Non-motor Symptoms in Essential Tremor

N. Jodoin, G. Rouleau, M. Panisset, 2014, Tremor and other hyperkinetic movements.

Orthoptic Treatment of Convergence Insufficiency in Parkinson’s Disease: A Case Series

E. Irving, R. Postuma, M. Panisset, 2017, Gerontology & geriatric medicine.

Mood stability during acute stimulator challenge in Parkinson's disease patients under long‐term treatment with subthalamic deep brain stimulation

A. Ptito, A. Dagher, A. Sadikot, 2007, Movement disorders : official journal of the Movement Disorder Society.

Absence of Mutation Enrichment for Genes Phylogenetically Conserved in the Olivocerebellar Motor Circuitry in a Cohort of Canadian Essential Tremor Cases

A. Rajput, G. Rouleau, M. Panisset, 2018, Molecular Neurobiology.

[SELECTIVE EFFECT OF LYOPHILIZATION ON A BACTERIAL POPULATION: SPECIAL CASE OF BCG].

M. Panisset, M. Quevillon, J. Benoit, 1964, Revue canadienne de biologie.

We continue to assert that MRI offers important advantages over CT scanning in the diagnosis of ICA dissection, and we believe this to be the investigation of choice in situations where this condition is suspected.

M. Panisset, 1990 .

Brain Connectivity Alterations Are Associated with the Development of Dementia in Parkinson's Disease

Natasa Kovacevic, Anthony Randal McIntosh, Jean-François Gagnon, 2016, Brain Connect..

Mental calculation in mild Alzheimer's disease: A pilot study

Oscar L. Lopez, Jordan Grafman, Michel Panisset, 1992 .